22UAy.DE
Latest Trade
85.00EURChange
-0.72(-0.84%)Volume
14,096Today's Range
-
86.3952 Week Range
-
108.90As of on the NASDAQ ∙ Minimum 15 minute delay
Previous Close | 85.72 |
|---|---|
Open | 85.34 |
Volume | 14,096 |
3M AVG Volume | 83.89 |
Today's High | 86.39 |
Today's Low | 85.00 |
52 Week High | 108.90 |
52 Week Low | 65.50 |
Shares Out (MIL) | 232.67 |
Market Cap (MIL) | 25,210.25 |
Forward P/E | -69.39 |
Dividend (Yield %) | -- |
Pfizer And Biontech Publish Results Of Study
Canada says Pfizer to slow deliveries of COVID-19 vaccines - procurement minister
EMA Says To Evaluate Safety Reports Of COVID-19 Vaccines From January
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Industry
Biotechnology & Drugs
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | -- |
Price To Book (MRQ) | 21.65 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 33.50 |
LT Debt To Equity (MRQ) | 18.93 |
Return on Investment (TTM) | -- |
Return on Equity (TTM) | -- |
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.